Amphiphilic Dendron-Coils, Micelles Thereof and Uses

US2016331685A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016331685-A1
Application numberUS-201514968867-A
CountryUS
Kind codeA1
Filing dateDec 14, 2015
Priority dateFeb 23, 2011
Publication dateNov 17, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention generally relates to the fields of drug delivery and cell capture. In particular, the invention relates to amphiphilic dendron-coils, micelles thereof and their use for drug delivery vehicles and/or cell capture.

First claim

Opening claim text (preview).

1 . A micelle comprising amphiphilic dendron-coils, wherein each amphiphilic dendron-coil comprises a non-peptidyl, hydrophobic core-forming block, a polyester dendron and a poly(ethylene) glycol (PEG) moiety. 2 . The micelle of claim 1 wherein the the non-peptidyl, hydrophobic core-forming block comprises polycaprolactone (PCL), poly(lactic acid) (PLA), poly(glycolic acid) (PGA) or poly(lactic-co-glycolic acid) (PLGA); wherein the polyester dendron is a generation 3 to generation 5 polyester dendron with either an acetylene or carboxylate core; and wherein the PEG moiety is a methoxy PEG (mPEG) moiety, amine-terminated PEG (PEG-NH 2 ) moiety, acetylated PEG (PEG-Ac) moiety, carboxylated PEG (PEG-COOH) moiety, thiol-terminated PEG (PEG-SH) moiety, N-hydroxysuccinimide-actived PEG (PEG-NHS) moiety, NH 2 -PEG-NH 2 moiety or NH 2 -PEG-COOH moiety. 3 - 8 . (canceled) 9 . The micelle of claim 1 or wherein the non-peptidyl, hydrophobic core-forming block has a molecular weight from about 0.5 kDa to about 20 kDa. 10 - 18 . (canceled) 19 . The micelle of claim 1 wherein the polyester dendron is a generation 3 (G3) dendron. 20 . The micelle of claim 1 wherein the polyester dendron is a generation 4 (G4) dendron. 21 . The micelle of claim 1 wherein the polyester dendron is a generation 5 (G5) dendron. 22 . The micelle of claim 19 wherein the polyester dendron is a generation 3 polyester-8-hydroxyl-1-acetylene bis-MPA dendron. 23 . The micelle of claim 1 wherein the PEG moiety is a methoxy PEG (mPEG) moiety, amine-terminated PEG (PEG-NH 2 ) moiety, acetylated PEG (PEG-Ac) moiety, carboxylated PEG (PEG-COOH) moiety, thiol-terminated PEG (PEG-SH) moiety, N-hydroxysuccinimide-actived PEG (PEG-NHS) moiety, NH 2 -PEG-NH 2 moiety or NH 2 -PEG-COOH moiety. 22 - 26 . (canceled) 27 . The micelle of claim 23 wherein the PEG moiety has a molecular weight from about 0.2 kDa to about 5 kDa. 28 - 31 . (canceled) 32 . The micelle of claim 1 further comprising one or more ligands conjugated to one or more PEG moieties. 33 . (canceled) 34 . The micelle of claim 1 further comprising a drug. 35 . The micelle of claim 34 wherein the drug is a cancer drug. 36 - 37 . (canceled) 38 . A composition comprising a micelle comprising amphiphilic dendron-coils, wherein each amphiphilic dendron-coil comprises a non-peptidyl, hydrophobic core-forming block, a polyester dendron and a poly(ethylene) glycol (PEG) moiety. 39 - 74 . (canceled) 75 . A method of delivering a drug to a patient comprising administering a composition comprising a micelle and a pharmaceutically acceptable carrier, wherein the micelle comprises amphiphilic dendron-coils and encapsulates the drug, and wherein each amphiphilic dendron-coil comprises a non-peptidyl, hydrophobic core-forming block, a polyester dendron and a poly(ethylene) glycol (PEG) moiety. 76 - 111 . (canceled) 112 . A method of capturing a cell from a sample comprising the steps of: exposing the sample to an immobilized amphiphilic dendron-coil comprising a non-peptidyl, hydrophobic core-forming block, a polyester dendron and a poly(ethylene) glycol (PEG) moiety with a ligand conjugated to the PEG, wherein the ligand binds to the cell; and capturing the cell by binding of the ligand to the cell. 113 - 145 . (canceled) 146 . An amphiphilic dendron-coil comprising a non-peptidyl, hydrophobic core-forming block, a polyester dendron and a poly(ethylene) glycol (PEG) moiety. 147 - 176 . (canceled) 177 . The amphiphilic dendron-coil of claim 146 further comprising a ligand conjugated to the PEG moiety. 178 . (canceled)

Assignees

Inventors

Classifications

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

  • Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title

  • Dendrimers · CPC title

  • Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin · CPC title

  • A61K9/1075Primary

    Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016331685A1 cover?
The invention generally relates to the fields of drug delivery and cell capture. In particular, the invention relates to amphiphilic dendron-coils, micelles thereof and their use for drug delivery vehicles and/or cell capture.
Who is the assignee on this patent?
Univ Illinois
What technology area does this patent fall under?
Primary CPC classification A61K9/1075. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).